Citalopram, Escitalopram and the QT Interval

被引:0
|
作者
Roden, D.
机构
来源
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2013年 / 55卷 / 1421期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:59 / 59
页数:1
相关论文
共 50 条
  • [3] Citalopram, escitalopram and prolonged QT: Warning or alarm?
    Alvarez, Enric
    Vieira, Sara
    Garcia-Moll, Xavier
    REVISTA DE PSIQUIATRIA Y SALUD MENTAL, 2014, 7 (03): : 147 - 150
  • [4] Citalopram (Celexa) and QT Interval Prolongation
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2012, 54 (1398): : 71 - 72
  • [5] Prevalence of QT/QTc prolongation, TdP and VTach in citalopram/escitalopram PC exposures
    Martin, T.
    Sullivan, S. S.
    CLINICAL TOXICOLOGY, 2014, 52 (07) : 772 - 772
  • [6] Impact of hospital pharmacist interventions on the combination of citalopram or escitalopram with other QT-prolonging drugs
    A. Chastang
    S. Renet
    J. Corny
    H. Beaussier
    A. Petre
    A. Lillo-Lelouet
    T. T. Phan Thi
    Y. Bézie
    International Journal of Clinical Pharmacy, 2019, 41 : 42 - 48
  • [7] Impact of hospital pharmacist interventions on the combination of citalopram or escitalopram with other QT-prolonging drugs
    Chastang, A.
    Renet, S.
    Corny, J.
    Beaussier, H.
    Petre, A.
    Lillo-Lelouet, A.
    Thi, T. T. Phan
    Bezie, Y.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 42 - 48
  • [8] Towards limiting QT interval prolongation and arrhythmia risk in citalopram use
    Zhang, Yihong
    Baranchuk, Adrian
    Hancox, Jules C.
    CARDIOLOGY JOURNAL, 2014, 21 (05) : 454 - 457
  • [9] Low proarrhythmic potential of escitalopram and citalopram in contrast to haloperidol despite significant QT-prolongation
    Frommeyer, G.
    Von Der Ahe, H.
    Bruecher, B.
    Milberg, P.
    Eckardt, 'L.
    EUROPEAN HEART JOURNAL, 2014, 35 : 260 - 260
  • [10] Prescribe Escitalopram Instead of Citalopram
    Keller, David L.
    AMERICAN JOURNAL OF MEDICINE, 2013, 126 (06): : E19 - E19